- Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P. Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res 2010; 25 (11): 2412-8.
- Agholme F, Isaksson H, Kuhstoss S, Aspenberg P. The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions. Bone 2011 (In Press).
- Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001; 10 (5): 537-43.
- Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001; 68 (3): 577-89.
- Chappard D, Chennebault A, Moreau M, Legrand E, Audran M, Basle MF. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. Bone 2001; 28 (1): 72-9.
- Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R, Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 2007; 4 (7): e249.
- Galli C, Passeri G, Macaluso GM. Osteocytes and WNT: the mechanical control of bone formation. J Dent Res 2010; 89 (4): 331-43.
- Kim JB, Leucht P, Lam K, Luppen C, Ten Berge D, Nusse R, Bone regeneration is regulated by wnt signaling. J Bone Miner Res 2007; 22 (12): 1913-23.
- Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280 (20): 19883-7.
- Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agostin D, Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 2008; 23 (6): 860-9.
- Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 2009; 24 (4): 578-88.
- Li X, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Grisanti M, Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats. J Bone Miner Res 2010; 25 (12): 2371-80.
- Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res 2009; 24 (10): 1651-61.
- Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, Doellgast G, Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 2010; 25 (5): 948-59.
- Ominsky MS, Li C, Li X, Tan HL, Lee E, Barrero M, Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of non-fractured bones. J Bone Miner Res 2011; 26 (5): 1012-21.
- Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Lowik CW, Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 2005; 19 (13): 1842-4.
- Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 2008; 283 (9): 5866-75.
- Tian X, Jee WS, Li X, Paszty C, Ke HZ. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Bone 2011; 48 (2): 197-201.
- Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS. Botox induced muscle paralysis rapidly degrades bone. Bone 2006; 38 (2): 257-64.
Acta Orthopaedica
Volume 82, 2011 - Issue 5